As of April 16, 2025, iTeos Therapeutics (ITOS) has a market cap of $0.23 billion USD. According to our data, iTeos Therapeutics is ranked No.6850 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.23 B |
-19.21%
|
Dec 31, 2024 | $0.28 B |
-29.86%
|
Dec 29, 2023 | $0.40 B |
-43.93%
|
Dec 30, 2022 | $0.71 B |
-58.05%
|
Dec 31, 2021 | $1.70 B |
37.67%
|
Dec 31, 2020 | $1.24 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Incyte
INCY
|
$11.31 B |
0.000 M
|
![]() USA
|
![]() Exelixis
EXEL
|
$10.23 B |
0.000 M
|
![]() USA
|
![]() Blueprint Medicines
BPMC
|
$5.21 B |
0.000 M
|
![]() USA
|
![]() BeiGene
BGNE
|
$20.21 B |
-1.816 B
|
![]() China
|
![]() Zai Lab
ZLAB
|
$3.33 B |
0.000 M
|
![]() China
|
![]() Arcus Biosciences
RCUS
|
$0.85 B |
-0.000 M
|
![]() USA
|
![]() MacroGenics
MGNX
|
$79.49 M |
-0.000 M
|
![]() USA
|
![]() Adaptimmune Therapeutics
ADAP
|
$64.18 M |
-0.000 M
|
![]() UK
|
Market Cap | = | ITOS Stock Price | * | ITOS Shares Outstanding |
= | $5.93 | * | 38.19 M | |
= | $0.23 B |